SERPINA4 and ovarian cancer: As shown in Fig. 3 d and e, overexpression of kallistatin significantly suppressed the tumorigenesis of ovarian cancer cells in vivo (0.430 ± 0.069 g vs. 0.148 ± 0.045 g, p = 0.009).